Bg pattern

ACETYLCYSTEINE RATIOPHARM 600 mg EFFERVSCENT TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ACETYLCYSTEINE RATIOPHARM 600 mg EFFERVSCENT TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show translation

Introducción

Prospecto: información para el usuario

Acetilcisteína ratiopharm 600 mg comprimidos efervescentes EFG

Lea todo el prospecto detenidamente antes de empezar a tomar el medicamento, porque contiene información importante para usted.

  • Conserve este prospecto, ya que puede tener que volver a leerlo.
  • Si tiene alguna duda, consulte a su médico o farmacéutico.
  • Este medicamento se le ha recetado solamente a usted y no debe dárselo a otras personas, aunque tengan los mismos síntomas, ya que puede perjudicarles.
  • Si experimenta efectos adversos, consulte a su médico o farmacéutico, incluso si se trata de efectos adversos que no aparecen en este prospecto. Ver sección 4.

Contenido del prospecto:

  1. Qué es Acetilcisteína ratiopharm y para qué se utiliza
  2. Qué necesita saber antes empezar a tomar Acetilcisteína ratiopharm 3. Cómo tomar Acetilcisteína ratiopharm
  3. Posibles efectos adversos
  4. Conservación de Acetilcisteína ratiopharm
  5. Contenido del envase e información adicional

1. Qué es Acetilcisteína ratiopharm y para qué se utiliza

Acetilcisteína ratiopharm 600 mg es un medicamento que pertenece al grupo de los medicamentos denominados mucolíticos/expectorantes.

Acetilcisteína está indicada como tratamiento complementario en los procesos respiratorios que cursan con aumento de la mucosidad excesiva o mucosidad espesa tales como bronquitis aguda y crónica, enfermedad pulmonar obstructiva crónica (EPOC), enfisema, atelectasia debida a obstrucción mucosa: complicaciones pulmonares de la fibrosis quística y otras patologías relacionadas.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Qué necesita saber antes de empezar a tomar Acetilcisteína ratiopharm

No tome Acetilcisteína ratiopharm sí

  • si es alérgico a la acetilcisteína o a alguno de los demás componentes de este medicamento (incluidos en la sección 6)
  • si padece úlcera gastrointestinal,
  • si sufre asma o insuficiencia respiratoria grave,
  • si padece fenilcetonuria.

Advertencias y precauciones

Consulte a su médico o farmacéutico antes de empezar a tomar este medicamento.

Muy raramente se han notificado reacciones cutáneas severas como el síndrome de Stevens-Johnson y síndrome de Lyell, asociados en el tiempo con la administración de acetilcisteína. Si producen cambios cutáneos o en las mucosas, se debe obtener consejo médico rápidamente y dejar de tomar acetilcisteína.

La detección de un olor a azufre, no indica que el preparado este alterado, este olor es propio del principio activo.

Otros medicamentos y Acetilcisteína ratiopharm

Informe a su médico o farmacéutico si está utilizando ha utilizado recientemente o pudiera tener que utilizar cualquier otro medicamento.

No se han descrito interacciones significativas con otros medicamentos o interferencias analíticas, aunque se recomienda no asociar con antitusivos o con medicamentos que disminuyen las secreciones bronquiales (atropina).

Embarazo y lactancia

Si está embarazada o en periodo de lactancia, cree que podría estar embarazada o tiene intención de quedarse embarazada, consulte a su médico o farmacéutico antes de utilizar este medicamento.

La administración de este medicamento en el embarazo o la lactancia debe hacerse bajo supervisión médica.

Acetilcisteína ratiopharm contiene aspartamo, sodio y sacarosa

Este medicamento contiene 20 mg de aspartamo por comprimido efervescente. El aspartamo contiene una fuente de fenilalanina que puede ser perjudicial en caso de padecer fenilcetonuria (FCN), una enfermedad genética rara en la que la fenilalanina se acumula debido a que el organismo no es capaz de eliminarla correctamente.

Este medicamento contiene 150,23 mg de sodio (componente principal de la sal de mesa/para cocinar) en cada comprimido efervescente. Esto equivale al 7,51% de la ingesta diaria máxima de sodio recomendada para un adulto.

Este medicamento contiene sacarosa. Si su médico le ha indicado que padece una intolerancia a ciertos azúcares, consulte a con él antes de tomar este medicamento.

3. Cómo tomarAcetilcisteína ratiopharm

Siga exactamente las instrucciones de administración de este medicamento indicadas por su médico o farmacéutico. En caso de duda, consulte de nuevo a su médico o farmacéutico.

Acetilcisteína ratiopharm es para administración oral.

Recuerde tomar su medicamento.

Su médico le indicará la duración de su tratamiento con Acetilcisteína ratiopharm.

No suspenda el tratamiento antes de consultar a su médico.

La dosis normal es:

Adultos y niños mayores de 7 años: 600 mg al día administrados en 1 toma diaria (600 mg) o en tres tomas (200 mg), cada 8 horas.

Niños de 2 a 7 años: 300 mg al día, repartidos en tres tomas (100 mg), cada 8 horas.

En niños menores de 7 años, para un mejor ajuste de la dosis, se recomienda la utilización de Acetilcisteína ratiopharm 200 mg sobres.

No administrar este medicamento en niños menores de 2años.

Fibrosis quística

Adultos y niños mayores de 7 años: 200-400 mg cada 8 horas.

Niños de 2 a 7 años: 200-400 mg cada 8 horas.

En está indicación, para un mejor ajuste de la dosis, se recomienda la utilización de Acetilcisteína ratiopharm 200 mg polvo para solución oral.

No administrar este medicamento en niños menores de 2 años.

Disolver el comprimido efervescente en un vaso de agua, de esta forma, se obtiene una solución de sabor agradable que puede beber directamente del vaso. El comprimido no está destinado a dividirse en partes iguales.

Si toma más Acetilcisteína ratiopharm del que debe

Si ha tomado más de lo que debe, consulte inmediatamente a su médico o a su farmacéutico.

En caso de sobredosis o ingestión accidental, consultar al Servicio de Información Toxicológica, Teléfono (91) 562 04 20, indicando el medicamento y la cantidad ingerida.

Si olvidó tomar Acetilcisteína ratiopharm

No tome una dosis doble para compensar las dosis olvidadas.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Posibles efectos adversos

Al igual que todos los medicamentos, este medicamento puede producir efectos adversos, aunque no todas las personas los sufran.

Trastornos del sistema inmunológico

Poco frecuentes:reacciones de hipersensibilidad por ejemplo prurito, urticaria, sarpullido, broncoespasmo

Trastornos del sistema nervioso

Poco frecuentes: dolor de cabeza

Trastornos del oído y del laberinto

Poco frecuentes: tinitus (acúfenos)

Trastornos gastrointestinales:

Poco frecuentes: dolor abdominal, nauseas, vómitos y diarreas.

Trastornos de la piel y del tejido subcutáneo

Muy raras: reacciones de hipersensibilidad acompañada de urticaria

Trastornos respiratorios, torácicos y mediastínicos

Raras: disnea (dificultad para respirar), broncoespasmo, (especialmente en pacientes con el sistema bronquial hiperreactivo en asma bronquial)

Comunicación de efectos adversos

Si experimenta cualquier tipo de efecto adverso, consulte a su médico o farmacéutico, incluso si se trata de posibles efectos adversos que no aparecen en este prospecto. También puede comunicarlos directamente a través del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano: http://www.notificaram.es/. Mediante la comunicación de efectos adversos usted puede contribuir a proporcionar más información sobre la seguridad de este medicamento.

5. Conservación de Acetilcisteína ratiopharma

Mantener este medicamento fuera de la vista y del alcance de los niños.

No utilice Acetilcisteína ratiopharm después de la fecha de caducidad que aparece en el envase después de CAD. La fecha de caducidad es el último día del mes que se indica.

No conservar a temperatura superior a 25 ºC.

Mantener en el envase original para protegerlo de la humedad.

Mantener el envase perfectamente cerrado.

Los medicamentos no se deben tirar por los desagües ni a la basura. Deposite los envases y los medicamentos que no necesita en el Punto SIGRE de la farmacia. En caso de duda pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que no necesita. De esta forma, ayudará a proteger el medio ambiente.

6. Contenido del envase e información adicional

Composición de Acetilcistetina ratiopharm 600 mg comprimidos efervescentes EFG

  • El principio activo es acetilcisteína. Cada comprimido efervescente contiene 600 mg de acetilcisteína.
  • Los demás componentes son: Ácido cítrico anhidro, hidrogenocarbonato de sodio, aroma de Limón (contiene sacarosa), polivinilpirrolidona, ácido adípico, aspartamo (E-951) e isopropanol.

Aspecto del producto y contenido del envase

Acetilcisteína ratiopharm 600 mg son comprimidos efervescentes blancos a ligeramente amarillentos, redondos biplanos con ranura en un lado y con olor a limón. El comprimido no está destinado a dividirse en partes iguales.

Cada envase contiene 20 comprimidos efervescentes.

Titular de la autorización de comercialización y responsable de la fabricación

Titular

ratiopharm España, S.A

c/ Anabel Segura 11, Edificio Albatros B 1ª planta

28108 Alcobendas, Madrid (España)

Responsable de la fabricación:

Merckle GmbH

Ludwig Merckle Strasse, 3

D- 89143. Blaubeuren

Alemania

Fecha de la última revisión de este prospecto: enero 2014

“La información detallada y actualizada de este medicamento está disponible en la página Web de la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) http://www.aemps.gob.es/ ”

Online doctors for ACETYLCYSTEINE RATIOPHARM 600 mg EFFERVSCENT TABLETS

Discuss questions about ACETYLCYSTEINE RATIOPHARM 600 mg EFFERVSCENT TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for ACETYLCYSTEINE RATIOPHARM 600 mg EFFERVSCENT TABLETS?
ACETYLCYSTEINE RATIOPHARM 600 mg EFFERVSCENT TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ACETYLCYSTEINE RATIOPHARM 600 mg EFFERVSCENT TABLETS?
The active ingredient in ACETYLCYSTEINE RATIOPHARM 600 mg EFFERVSCENT TABLETS is acetylcysteine. This information helps identify medicines with the same composition but different brand names.
Who manufactures ACETYLCYSTEINE RATIOPHARM 600 mg EFFERVSCENT TABLETS?
ACETYLCYSTEINE RATIOPHARM 600 mg EFFERVSCENT TABLETS is manufactured by Teva Pharma S.L.U.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ACETYLCYSTEINE RATIOPHARM 600 mg EFFERVSCENT TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ACETYLCYSTEINE RATIOPHARM 600 mg EFFERVSCENT TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ACETYLCYSTEINE RATIOPHARM 600 mg EFFERVSCENT TABLETS?
Other medicines with the same active substance (acetylcysteine) include ACETYLCYSTEINE ABEX 600 mg EFFERVSCENT TABLETS, ACETYLCYSTEINE ALTER 600 mg EFFERVSCENT TABLETS, ACETYLCYSTEINE AUROVITAS 200 mg EFFERVSCENT TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media